Short answer
Gossamer Bio, Inc. (GOSS) filed an 8-K current report with the SEC on July 15, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws), Item 5.07 (Submission of Matters to a Vote of Security Holders). Stockholders approved the Restated 2019 Incentive Award Plan on July 14, 2026.
Gossamer Bio, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Stockholders approved the Restated 2019 Incentive Award Plan on July 14, 2026
- Plan increases authorized Common Stock shares available for equity awards, creating potential dilution
- Approval satisfied a condition tied to the $200.0 million Existing Convertible Notes exchange offer
- Exchange Offer closed June 4, 2026 after early settlement of the 5.00% Convertible Senior Notes due 2027
Item 5.03 · Amendments to Articles of Incorporation or Bylaws
- Stockholder-approved charter amendment effective July 14, 2026
- Authorized common shares increased from 700 million to 4 billion
- Capacity supports conversion of 7.50% notes due 2030 and exercise of newly issued warrants
- Expanded share authorization creates substantial potential dilution for existing shareholders
Item 5.07 · Submission of Matters to a Vote of Security Holders
- Stockholders approved potential issuance exceeding 20%, including $72.0M convertible notes, make-whole shares, and 135,789,000 warrants
- Share authorization increased from 700M to 4B, enabling financing-related issuances and expanded equity-plan capacity
- Restated equity plan approved, increasing shares available for issuance
- Reverse-split proposal approved through 30 alternative amendments, with proportional authorized-share reductions
- Adjournment vote unnecessary after all four substantive proposals passed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Gossamer Bio, Inc. 8-K filings
Get the next GOSS 8-K as it lands
Follow GOSS for push alerts, or ask the research agent what this filing means.